Furthermore, inducible MEF2C expression or KO ETP-ALL models were developed from the LOUCY cell line to further study the effect of MEF2C on gene regulation, differentiation, growth, and survival in-depth and to identify clinically relevant inhibitors that can impair its function. The gene discussed is MEF2C; the disease is acute lymphoblastic leukemia.